×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Continuing Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine (PIM) and DIA. PIM is accredited by the ACCME to provide continuing medical education for physicians.
PIM designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 3.25 contact hours or .325 continuing education units (CEUs).Type of Activity: Application 0286-0000-18-500-L04-P
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This educational activity for 3.25 contact hours is provided by Postgraduate Institute for Medicine.
DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).
As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer up to .3 CEUs for this program. Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.
Certificate Program Statement
This program is part of DIA’s Certificate Program and is awarded the following:- Clinical Research Certificate Program: 2 Elective Units
- Regulatory Affairs Certificate Program: 2 Elective Units
To view DIA’s Grievance Policy, visit DIAglobal.org/CE
| Name | Credit Type | Max Credits | CEU |
| #20: Real World Evidence Studies | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #20: Real World Evidence Studies | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #20: Real World Evidence Studies | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #20: Real World Evidence Studies | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #21: The IDMP Challenge: Points to Consider for Ph | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #21: The IDMP Challenge: Points to Consider for Ph | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #21: The IDMP Challenge: Points to Consider for Ph | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #21: The IDMP Challenge: Points to Consider for Ph | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #22: Protocol Co-Design with Patients and Advocate | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #22: Protocol Co-Design with Patients and Advocate | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #22: Protocol Co-Design with Patients and Advocate | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #22: Protocol Co-Design with Patients and Advocate | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #23: R&D QA Comprehensive Quality Strategy | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #23: R&D QA Comprehensive Quality Strategy | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #23: R&D QA Comprehensive Quality Strategy | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #23: R&D QA Comprehensive Quality Strategy | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #24: Preparing for a US FDA Advisory Committee Mee | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #24: Preparing for a US FDA Advisory Committee Mee | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #24: Preparing for a US FDA Advisory Committee Mee | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #24: Preparing for a US FDA Advisory Committee Mee | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #25: Precedent: A Driver of Regulatory Strategy | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #25: Precedent: A Driver of Regulatory Strategy | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #25: Precedent: A Driver of Regulatory Strategy | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #27: The Evolving Role of Payers in Drug Developme | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #27: The Evolving Role of Payers in Drug Developme | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #27: The Evolving Role of Payers in Drug Developme | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #27: The Evolving Role of Payers in Drug Developme | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #28: Preparing Documents for Disclosure and Public | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #28: Preparing Documents for Disclosure and Public | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #28: Preparing Documents for Disclosure and Public | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #28: Preparing Documents for Disclosure and Public | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #29: Leadership: How to Organize and Lead People | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #29: Leadership: How to Organize and Lead People | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #29: Leadership: How to Organize and Lead People | Credit TypePMI | Max Credits3.25 | CEU0.000 |
| #29: Leadership: How to Organize and Lead People | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #30: Implementing a Risk-Based Monitoring Solution | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #30: Implementing a Risk-Based Monitoring Solution | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #30: Implementing a Risk-Based Monitoring Solution | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #31: Machine Learning in Pharmacovigilance | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #31: Machine Learning in Pharmacovigilance | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #31: Machine Learning in Pharmacovigilance | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #31: Machine Learning in Pharmacovigilance | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #33: Quality Tolerance Limits/Issue Management | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #33: Quality Tolerance Limits/Issue Management | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #33: Quality Tolerance Limits/Issue Management | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #33: Quality Tolerance Limits/Issue Management | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #34: Japan Regulatory Environment: Overview of the | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #34: Japan Regulatory Environment: Overview of the | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #34: Japan Regulatory Environment: Overview of the | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #34: Japan Regulatory Environment: Overview of the | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #35: FDA Advisory Committee Purpose and Non-inferi | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #35: FDA Advisory Committee Purpose and Non-inferi | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #35: FDA Advisory Committee Purpose and Non-inferi | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #35: FDA Advisory Committee Purpose and Non-inferi | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #36: Value Pricing Bootcamp: A Crash Course in How | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #36: Value Pricing Bootcamp: A Crash Course in How | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #36: Value Pricing Bootcamp: A Crash Course in How | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #36: Value Pricing Bootcamp: A Crash Course in How | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #37: Data Visualization in the Life Sciences | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #37: Data Visualization in the Life Sciences | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #37: Data Visualization in the Life Sciences | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #37: Data Visualization in the Life Sciences | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #40: Smart, Innovative Risk-based Auditing: Shifti | Credit TypeCME | Max Credits6.50 | CEU0.000 |
| #40: Smart, Innovative Risk-based Auditing: Shifti | Credit TypeIACET | Max Credits6.50 | CEU0.700 |
| #40: Smart, Innovative Risk-based Auditing: Shifti | Credit TypeRN | Max Credits6.50 | CEU0.000 |
| #42: Back to the Future: Combination Products in t | Credit TypeACPE | Max Credits6.50 | CEU0.650 |
| #42: Back to the Future: Combination Products in t | Credit TypeCME | Max Credits6.50 | CEU0.000 |
| #42: Back to the Future: Combination Products in t | Credit TypeIACET | Max Credits6.50 | CEU0.700 |
| #42: Back to the Future: Combination Products in t | Credit TypeRN | Max Credits6.50 | CEU0.000 |
| DIA 2018 Global Annual Meeting | Credit TypeACPE | Max Credits17.50 | CEU1.750 |
| DIA 2018 Global Annual Meeting | Credit TypeCME | Max Credits17.50 | CEU0.000 |
| DIA 2018 Global Annual Meeting | Credit TypeIACET | Max Credits32.00 | CEU3.200 |
| DIA 2018 Global Annual Meeting | Credit TypePMI | Max Credits13.75 | CEU0.000 |
| DIA 2018 Global Annual Meeting | Credit TypeRN | Max Credits17.50 | CEU0.000 |
Statement of Credit:
If you would like to receive a statement of credit, you must attend the short course, scan your name badge within 45 minutes after the start of the short course, and complete the online credit request process through My Transcript. My Transcript will be available for credit requests on Tuesday, July 3, 2018.To access My Transcript:
- Visit DIAglobal.org, select “Sign in” and you will be prompted for your user ID and password
- Choose MENU, found in the upper left corner
- Under CONFERENCES select “Continuing Education"
- Select the blue “My Transcript” button followed by “Credit Request” to process your credit request for the short course
Have an account?